Aprepitant in the Prevention of Cisplatin-Induced Delayed Emesis: a Double-Blind Randomized Trial.

Trial Profile

Aprepitant in the Prevention of Cisplatin-Induced Delayed Emesis: a Double-Blind Randomized Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 03 Jun 2014

At a glance

  • Drugs Aprepitant (Primary) ; Dexamethasone; Metoclopramide
  • Indications Chemotherapy-induced nausea and vomiting
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
    • 09 Jan 2014 Status changed from recruiting to discontinued as reported in ClinicalTrials.gov record.
    • 17 Mar 2012 New source identified and integrated (EudraCT2008-001339-37; European Clinical Trials Database).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top